Skip to main content

Day: January 28, 2021

Hagar hf.: Breyting á framkvæmdastjórn

Magnús Magnússon hefur verið ráðinn framkvæmdastjóri stefnumótunar og rekstrar hjá Högum og mun hefja störf þann 1. febrúar. Guðrún Eva Gunnarsdóttir mun samhliða því taka við sem framkvæmdastjóri fjármálasviðs Haga. Guðrún þekkir vel til starfsins en hún gegndi þeirri stöðu fram til 2019, en hefur síðan þá starfað sem framkvæmdastjóri rekstrar og samstæðu Haga.Magnús hefur mikla reynslu af stefnumótun og almennum rekstri, bæði hérlendis og erlendis. Hann hefur undanfarið ár starfað sem sjálfstæður ráðgjafi, eftir að hafa leitt stefnumótunarteymi Marel árin þar á undan. Þar áður starfaði Magnús sem ráðgjafi hjá alþjóðlega ráðgjafafyrirtækinu McKinsey & Company þar sem Magnús aðstoðaði fjölda alþjóðlegra fyrirtækja með stefnumótun, rekstrarumbætur og stærri umbreytingar, og enn áður hjá hugbúnaðarfyrirtækinu AGR Dynamics. Magnús er...

Continue reading

Visteon to announce fourth-quarter and full-year 2020 results on Thursday, Feb. 18

VAN BUREN TOWNSHIP, Mich., Jan. 28, 2021 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC) plans to release its fourth-quarter and full-year 2020 financial results prior to 7 a.m. ET on Thursday, Feb. 18. The company will host a conference call for the investment community at 9 a.m. ET to discuss the results and related matters. The conference call also is available to the general public via a live audio webcast.The dial-in numbers to participate in the call are:U.S./Canada: 866-411-5196Outside U.S./Canada: 970-297-2404Conference ID: 5096046(Call approximately 10 minutes before the start of the conference.)The conference call and live audio webcast, related presentation materials, news release and other supplemental information will be accessible in the Investors section of Visteon’s website.A replay of the conference call will...

Continue reading

Sharps Compliance Reports Fiscal 2021 Second Quarter Results

Second Quarter Revenue of $17.0 million, increased 17% from the prior yearSecond Quarter Customer Billings of $18.5 million, increased 24% over the prior yearRetail market billings increased 46%; Long-Term Care market billings increased 56%; Pharmaceutical Manufacturer market billings grew 35%Route-Based Pickup billings increased 41% for the quarterSecond Quarter Net Income of $0.07 per shareCompany now expects approximately $15 Million in COVID-19 related advance mailback orders in the March quarter, up from previous expectation of $10 millionRobust COVID-19 related mailback order activity; Playing a key role in COVID-19 vaccine programs in Retail and Long-Term Care SettingsHOUSTON, Jan. 28, 2021 (GLOBE NEWSWIRE) — Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive...

Continue reading

Endeavour Silver Provides 2021 Production and Cost Guidance, Forecasting 3.6-4.3 Million oz Silver and 31,000-35,500 oz Gold, or 6.1-7.1 Million oz Silver Equivalent

VANCOUVER, British Columbia, Jan. 28, 2021 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (TSX: EDR, NYSE: EXK) released today the 2021 production and cost guidance for its three silver-gold mines in Mexico, the Guanacevi mine in Durango state, the Bolanitos mine in Guanajuato state and the El Compas mine in Zacatecas state. The Company also provides its 2021 capital and exploration budgets for the three mines and several exploration and development projects (all dollar amounts in US$).2021 Production and Cost Guidance HighlightsIn 2021, silver production is expected to range from 3.6 to 4.3 million ounces (oz) and gold production is anticipated to be in the 31,000 to 35,500 oz range. Silver equivalent production is forecasted to total 6.1-7.1 million oz at an 80:1 silver:gold ratio.Consolidated cash costs and all-in sustaining costs...

Continue reading

Northrop Grumman Releases Fourth Quarter and Full-Year 2020 Financial Results

FALLS CHURCH, Va., Jan. 28, 2021 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its fourth quarter and full-year 2020 financial results. A copy of the earnings release has been furnished in the company’s Form 8-K filing and is also available on the company’s investor relations website at http://investor.northropgrumman.com.As previously announced, Northrop Grumman will webcast its earnings conference call at 9 a.m. Eastern time today. A live audio broadcast of the conference call will be available on http://investor.northropgrumman.com. To listen to the call, go to the website at least 15 minutes before the call to register, download and install any needed audio software.Northrop Grumman solves the toughest problems in space, aeronautics, defense and cyberspace to meet the ever evolving needs of our...

Continue reading

Pharmacy Benefit Management Market 2021 Size, Share, Growth, Trends, Analysis, Competitive Analysis, Forecast Report 2020-2027

Pune, India, Jan. 28, 2021 (GLOBE NEWSWIRE) — The global Pharmacy Benefit Management Market size is set to expand at a notable pace in the forthcoming years owing to the increasing efforts by creative enterprises to lower prescription drug prices, finds Fortune Business Insights™ in its report, titled “Pharmacy Benefit Management Market Size, Share & Industry Analysis, By Service (Specialty Pharmacy Services, Benefit Plan Design & Administration, Pharmacy Claims Processing, Formulary Management, Others), By Service Providers (Insurance Companies, Retail Pharmacies, Standalone PBMs) and Regional Forecast 2020-2027”.With prescription drugs becoming unaffordable without insurance cover, certain companies have been coming up with novel mechanisms to reduce medication costs and enhance price transparency of drugs. For example,...

Continue reading

Brunswick Corporation Releases Fourth Quarter & Full Year 2020 Earnings

METTAWA, Ill., Jan. 28, 2021 (GLOBE NEWSWIRE) — Brunswick Corporation (NYSE: BC) today has released its fourth quarter and full year 2020 financial results. A complete and full-text financial results press release is available on the Company’s website at www.brunswick.com/investors.  The results will also be available on the SEC’s website with the Form 8-K filing of the release at https://goo.gl/wJQN1.The Company will hold a conference call today at 10 a.m. CST hosted by David M. Foulkes, Chief Executive Officer, Ryan M. Gwillim – Senior Vice President and Chief Financial Officer, and Brent G. Dahl – Vice President of Investor Relations.The call will be broadcast over the Internet at www.brunswick.com/investors. To listen to the call, go to the website at least 15 minutes before the call to register, download and install any...

Continue reading

Global WholeHealth Partners Corp. (OTC:GWHP) Announces That It has Signed an Agreement with Charles Strongo for the Right to Sell and Manufacture Biodegradable Plastic for Medical Devices

Global Wholehealth Partners Corp. is Preparing Itself to be the First Fully Green Medical Device Supplier, by Using  Biodegradable Plastics for All Cassettes, Midstream, Urine Cups and Other Testing Devices. A Biodegradable Material for Producing a Medical Device is the Next Step in a Clearer EnvironmentSAN CLEMENTE, CA, Jan. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Global WholeHealth Partners Corp. (OTC:GWHP) announces today that it has signed an agreement with Charles Strongo for the right to sell and manufacture Biodegradable plastic for medical devices. Provisional Patent number 63/054,139, as mentioned in 8k filing on 01/21/2021.Global WholeHealth Partners Corp. (OTC:GWHP) understands the growth needed in the in-vitro diagnostic segment and the need for more rapid tests, and at the same time understands that we all need...

Continue reading

Compounding Pharmacy Market 2021 Size, Share, Growth, Trends, Analysis, Revenue, Competitive Landscape, Forecast Report – 2020-2027

Pune, India, Jan. 28, 2021 (GLOBE NEWSWIRE) — The global compounding pharmacy market size is expected to gain momentum backed by the growing demand for customized drugs and the rising geriatric population globally. This information is published by Fortune Business Insights in its upcoming report, titled, “Compounding Pharmacy Market Size, Share & Industry Analysis, By Application (Pain Management, Dermatology, Hormone Replacement Therapy, Oncology), By Service (Ingredient Alteration, Application or Delivery Alteration, Pharmaceutical Dosage Alteration, Filling Supply Shortages), By Route of Administration (Oral, Topical, Parenteral, Rectal), By Usage (Pediatrics, Geriatrics, Adults, Veterinary) and Regional Forecast, 2020-2027.”Compounding pharmacy is a term that refers to the consumption of custom medicines sourced from the...

Continue reading

Amalgamated Bank Reports Fourth Quarter and Full Year 2020 Financial Results

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) — Amalgamated Bank (Nasdaq: AMAL) (“Amalgamated” or the “Bank”) today announced financial results for the fourth quarter and full year ended December 31, 2020.Fourth Quarter 2020 HighlightsNet income of $13.8 million, or $0.44 per diluted share, compared to $12.5 million, or $0.40 per diluted share, for the third quarter of 2020 and $12.0 million, or $0.37 per diluted share for the fourth quarter of 2019Core net income (non-GAAP)[1] of $13.8 million, or $0.44 per diluted share, compared to $16.8 million, or $0.54 per diluted share for the third quarter of 2020 and $12.6 million, or $0.39 per diluted share, for the fourth quarter of 2019Deposit decline of $682.3 million, primarily due to the election cycle, to $5.3 billion compared to a balance of $6.0 billion on September 30, 2020Total loans...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.